Alteration in basal and depolarization induced transcriptional network in iPSC derived neurons from Timothy syndrome

Genome Medicine

Volumn 6, Issue 10, 2014, Pages

  Tian, Yuan ^a,b   Voineagu, Irina ^c   Paşca, Sergiu P ^d   Won, Hyejung ^a   Chandran, Vijayendran ^a   Horvath, Steve ^e   Dolmetsch, Ricardo E ^f,g   Geschwind, Daniel H ^a,b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f STANFORD UNIVERSITY   (United States)

^g NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL L TYPE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MYOCYTE ENHANCER FACTOR 2; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR NFAT;

ARTICLE; AUTISM; BINDING SITE; CONTROLLED STUDY; DEPOLARIZATION; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC PROCEDURES; HUMAN; HUMAN CELL; INTELLECTUAL IMPAIRMENT; MONOGENIC DISORDER; NERVE CELL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; PLEIOTROPY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIMOTHY SYNDROME; TRANSCRIPTION REGULATION; WEIGHTED GENE CO EXPRESSION NETWORK ANALYSIS;

EID: 84927922272     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-014-0075-5     Document Type: Article

References (87)

1. Bading H. Nuclear calcium signalling in the regulation of brain function. Nat Rev Neurosci 2013, 14:593-608. 10.1038/nrn3531, 23942469.
2. Catterall WA, Leal K, Nanou E. Calcium channels and short-term synaptic plasticity. J Biol Chem 2013, 288:10742-10749. 10.1074/jbc.R112.411645, 23400776.
3. Ebert DH, Greenberg ME. Activity-dependent neuronal signalling and autism spectrum disorder. Nature 2013, 493:327-337. 10.1038/nature11860, 23325215.
4. Bading H, Ginty DD, Greenberg ME. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 1993, 260:181-186. 10.1126/science.8097060, 8097060.
5. Bhat S, Dao DT, Terrillion CE, Arad M, Smith RJ, Soldatov NM, Gould TD. CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog Neurobiol 2012, 99:1-14. 10.1016/j.pneurobio.2012.06.001, 22705413.
6. Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 2001, 294:333-339. 10.1126/science.1063395, 11598293.
7. Barrett CF, Tsien RW. The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels. Proc Natl Acad Sci U S A 2008, 105:2157-2162. 10.1073/pnas.0710501105, 18250309.
8. Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, Schwartz PJ, Joseph RM, Condouris K, Tager-Flusberg H, Priori SG, Sanguinetti MC, Keating MT. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119:19-31. 10.1016/j.cell.2004.09.011, 15454078.
9. Splawski I, Timothy KW, Priori SG, Napolitano C, Bloise R: Timothy Syndrome. In GeneReviews(R). Edited by Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K. Seattle, WA: University of Washington; 1993-2014..
10. Ruan Y, Bloise R, Napolitano C, Priori SG. L-Type Calcium Channel Disease. Electrical Diseases of the Heart 2013, 209-217. Springer, London, 10.1007/978-1-4471-4881-4_12.
11. Hoischen A, Krumm N, Eichler EE. Prioritization of neurodevelopmental disease genes by discovery of new mutations. Nat Neurosci 2014, 17:764-772. 10.1038/nn.3703, 24866042.
12. Murdoch JD, State MW. Recent developments in the genetics of autism spectrum disorders. Curr Opin Genet Dev 2013, 23:310-315. 10.1016/j.gde.2013.02.003, 23537858.
13. O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG, Carvill G, Kumar A, Lee C, Ankenman K, Munson J, Hiatt JB, Turner EH, Levy R, O'Day DR, Krumm N, Coe BP, Martin BK, Borenstein E, Nickerson DA, Mefford HC, Doherty D, Akey JM, Bernier R, Eichler EE, Shendure J. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012, 338:1619-1622. 10.1126/science.1227764, 23160955.
14. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379. 10.1016/S0140-6736(12)62129-1.
15. Tao X, West AE, Chen WG, Corfas G, Greenberg ME. A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF. Neuron 2002, 33:383-395. 10.1016/S0896-6273(01)00561-X, 11832226.
16. West AE. Biological functions and transcriptional targets of CaRF in neurons. Cell Calcium 2011, 49:290-295. 10.1016/j.ceca.2011.04.003, 21565403.
17. Mao Z, Bonni A, Xia F, Nadal-Vicens M, Greenberg ME. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 1999, 286:785-790. 10.1126/science.286.5440.785, 10531066.
18. Potthoff MJ, Olson EN. MEF2: a central regulator of diverse developmental programs. Development 2007, 134:4131-4140. 10.1242/dev.008367, 17959722.
19. Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell 2002, 109:S67-S79. 10.1016/S0092-8674(02)00699-2, 11983154.
20. Nguyen T, Di Giovanni S. NFAT signaling in neural development and axon growth. Int J Dev Neurosci 2008, 26:141-145. 10.1016/j.ijdevneu.2007.10.004, 18093786.
21. Hardingham GE, Arnold FJ, Bading H. Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat Neurosci 2001, 4:261-267. 10.1038/85109, 11224542.
22. Hardingham GE, Chawla S, Johnson CM, Bading H. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 1997, 385:260-265. 10.1038/385260a0, 9000075.
23. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001, 2:599-609. 10.1038/35085068, 11483993.
24. Silva AJ, Kogan JH, Frankland PW, Kida S. CREB and memory. Annu Rev Neurosci 1998, 21:127-148. 10.1146/annurev.neuro.21.1.127, 9530494.
25. Paşca SP, Portmann T, Voineagu I, Yazawa M, Shcheglovitov A, Pasca AM, Cord B, Palmer TD, Chikahisa S, Nishino S, Bernstein JA, Hallmayer J, Geschwind DH, Dolmetsch RE. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med 2011, 17:1657-1662. 10.1038/nm.2576, 22120178.
26. Krey JF, Pasca SP, Shcheglovitov A, Yazawa M, Schwemberger R, Rasmusson R, Dolmetsch RE. Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nat Neurosci 2013, 16:201-209. 10.1038/nn.3307, 23313911.
27. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9:559. 10.1186/1471-2105-9-559, 19114008.
28. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 2005, 4:1544-6115.
29. Carter ME, Brunet A. FOXO transcription factors. Curr Biol 2007, 17:R113-R114. 10.1016/j.cub.2007.01.008, 17307039.
30. Salih DA, Rashid AJ, Colas D, de la Torre-Ubieta L, Zhu RP, Morgan AA, Santo EE, Ucar D, Devarajan K, Cole CJ, Madison DV, Shamloo M, Butte AJ, Bonni A, Josselyn SA, Brunet A. FoxO6 regulates memory consolidation and synaptic function. Genes Dev 2012, 26:2780-2801. 10.1101/gad.208926.112, 23222102.
31. Ozcan L, Wong CC, Li G, Xu T, Pajvani U, Park SK, Wronska A, Chen BX, Marks AR, Fukamizu A, Backs J, Singer HA, Yates JR, Accili D, Tabas I. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metab 2012, 15:739-751. 10.1016/j.cmet.2012.03.002, 22503562.
32. Dick O, Bading H. Synaptic activity and nuclear calcium signaling protect hippocampal neurons from death signal-associated nuclear translocation of FoxO3a induced by extrasynaptic N-methyl-D-aspartate receptors. J Biol Chem 2010, 285:19354-19361. 10.1074/jbc.M110.127654, 20404335.
33. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384. 10.1038/nature10110, 21614001.
34. Parikshak NN, Luo R, Zhang A, Won H, Lowe JK, Chandran V, Horvath S, Geschwind DH. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 2013, 155:1008-1021. 10.1016/j.cell.2013.10.031, 24267887.
35. Konopka G, Wexler E, Rosen E, Mukamel Z, Osborn GE, Chen L, Lu D, Gao F, Gao K, Lowe JK, Geschwind DH. Modeling the functional genomics of autism using human neurons. Mol Psychiatry 2012, 17:202-214. 10.1038/mp.2011.60, 21647150.
36. Allen JD, Xie Y, Chen M, Girard L, Xiao G. Comparing statistical methods for constructing large scale gene networks. PLoS One 2012, 7:e29348. 10.1371/journal.pone.0029348, 22272232.
37. Horvath S, Dong J. Geometric interpretation of gene coexpression network analysis. PLoS Comput Biol 2008, 4:e1000117. 10.1371/journal.pcbi.1000117, 18704157.
38. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 1995, 57:289-300.
39. Csardi G, Nepusz T: The igraph software package for complex network research.Inter J Complex Syst 2006, 1695: []., http://igraph.org
40. Langfelder P, Luo R, Oldham MC, Horvath S. Is my network module preserved and reproducible?. PLoS Comput Biol 2011, 7:e1001057. 10.1371/journal.pcbi.1001057, 21283776.
41. Stein JL, de la Torre-Ubieta L, Tian Y, Parikshak NN, Hernandez IA, Marchetto MC, Baker DK, Lu D, Hinman CR, Lowe JK, Wexler EM, Muotri AR, Gage FH, Kosik KS, Geschwind DH. A quantitative framework to evaluate modeling of cortical development by neural stem cells. Neuron 2014, 83:69-86. 10.1016/j.neuron.2014.05.035, 24991955.
42. Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, Sousa AM, Pletikos M, Meyer KA, Sedmak G, Guennel T, Shin Y, Johnson MB, Krsnik Z, Mayer S, Fertuzinhos S, Umlauf S, Lisgo SN, Vortmeyer A, Weinberger DR, Mane S, Hyde TM, Huttner A, Reimers M, Kleinman JE, Sestan N. Spatio-temporal transcriptome of the human brain. Nature 2011, 478:483-489. 10.1038/nature10523, 22031440.
43. Smyth GK. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions Using R and Bioconductor 2005, 397-420. Springer, New York, 10.1007/0-387-29362-0_23.
44. Zambon AC, Gaj S, Ho I, Hanspers K, Vranizan K, Evelo CT, Conklin BR, Pico AR, Salomonis N. GO-Elite: a flexible solution for pathway and ontology over-representation. Bioinformatics 2012, 28:2209-2210. 10.1093/bioinformatics/bts366, 22743224.
45. Mckee AE, Neretti N, Carvalho LE, Meyer CA, Fox EA, Brodsky AS, Silver PA. Exon expression profiling reveals stimulus-mediated exon use in neural cells. Genome Biol 2007, 8:R159. 10.1186/gb-2007-8-8-r159, 17683528.
46. Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA, Laptewicz M, Barbara-Haley K, Kuersten S, Markenscoff-Papadimitriou E, Kuhl D, Bito H, Worley PF, Kreiman G, Greenberg ME. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010, 465:182-U165.
47. Basu SN, Kollu R, Banerjee-Basu S. AutDB: a gene reference resource for autism research. Nucleic Acids Res 2009, 37:D832-D836. 10.1093/nar/gkn835, 19015121.
48. Lubs HA, Stevenson RE, Schwartz CE. Fragile X and X-linked intellectual disability: four decades of discovery. Am J Hum Genet 2012, 90:579-590. 10.1016/j.ajhg.2012.02.018, 22482801.
49. Inlow JK, Restifo LL. Molecular and comparative genetics of mental retardation. Genetics 2004, 166:835-881. 10.1534/genetics.166.2.835, 15020472.
50. Ropers HH. Genetics of intellectual disability. Curr Opin Genet Dev 2008, 18:241-250. 10.1016/j.gde.2008.07.008, 18694825.
51. van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Annu Rev Genet 2011, 45:81-104. 10.1146/annurev-genet-110410-132512, 21910631.
52. Frith MC, Fu Y, Yu L, Chen JF, Hansen U, Weng Z. Detection of functional DNA motifs via statistical over-representation. Nucleic Acids Res 2004, 32:1372-1381. 10.1093/nar/gkh299, 14988425.
53. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, Kloos DU, Land S, Lewicki-Potapov B, Michael H, Munch R, Reuter I, Rotert S, Saxel H, Scheer M, Thiele S, Wingender E. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 2003, 31:374-378. 10.1093/nar/gkg108, 12520026.
54. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I, Chekmenev D, Krull M, Hornischer K, Voss N, Stegmaier P, Lewicki-Potapov B, Saxel H, Kel AE, Wingender E. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 2006, 34:D108-D110. 10.1093/nar/gkj143, 16381825.
55. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 2011, 9:e1001046. [http://genome.ucsc.edu/ENCODE/dataMatrix/encodeChipMatrixHuman.html], 10.1371/journal.pbio.1001046.
56. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis C, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R, Khatun J, Lajoie BR, Landt SG, Lee BK, Pauli F, Rosenbloom KR, Sabo P, Safi A, Sanyal A, Shoresh N, Simon JM, Song L, Trinklein ND, Altshuler RC, Birney E, Brown JB, Cheng C, Djebali S, Dong XJ, Dunham I, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. 10.1038/nature11247.
57. Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR, Ma'ayan A. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 2010, 26:2438-2444. 10.1093/bioinformatics/btq466, 20709693.
58. He XB, Yi SH, Rhee YH, Kim H, Han YM, Lee SH, Lee H, Park CH, Lee YS, Richardson E, Kim BW. Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications. Stem Cells 2011, 29:1861-1873. 10.1002/stem.739, 21922608.
59. Hua JY, Smear MC, Baier H, Smith SJ. Regulation of axon growth in vivo by activity-based competition. Nature 2005, 434:1022-1026. 10.1038/nature03409, 15846347.
60. Schor IE, Rascovan N, Pelisch F, Allo M, Kornblihtt AR. Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing. Proc Natl Acad Sci U S A 2009, 106:4325-4330. 10.1073/pnas.0810666106, 19251664.
61. Adams DS, Levin M. Endogenous voltage gradients as mediators of cell-cell communication: strategies for investigating bioelectrical signals during pattern formation. Cell Tissue Res 2013, 352:95-122. 10.1007/s00441-012-1329-4, 22350846.
62. Spitzer NC. Electrical activity in early neuronal development. Nature 2006, 444:707-712. 10.1038/nature05300, 17151658.
63. Sundelacruz S, Levin M, Kaplan DL. Role of membrane potential in the regulation of cell proliferation and differentiation. Stem Cell Rev 2009, 5:231-246. 10.1007/s12015-009-9080-2, 19562527.
64. Nagamani SC, Zhang F, Shchelochkov OA, Bi W, Ou Z, Scaglia F, Probst FJ, Shinawi M, Eng C, Hunter JV, Sparagana S, Lagoe E, Fong CT, Pearson M, Doco-Fenzy M, Landais E, Mozelle M, Chinault AC, Patel A, Bacino CA, Sahoo T, Kang SH, Cheung SW, Lupski JR, Stankiewicz P. Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment. J Med Genet 2009, 46:825-833. 10.1136/jmg.2009.067637, 19584063.
65. Thevenon J, Callier P, Andrieux J, Delobel B, David A, Sukno S, Minot D, Mosca Anne L, Marle N, Sanlaville D. 12p13.33 microdeletion including ELKS/ERC1, a new locus associated with childhood apraxia of speech. Eur J Hum Genet 2013, 21:82-88. 10.1038/ejhg.2012.116, 22713806.
66. Aleksic B, Kushima I, Hashimoto R, Ohi K, Ikeda M, Yoshimi A, Nakamura Y, Ito Y, Okochi T, Fukuo Y, Yasuda Y, Fukumoto M, Yamamori H, Ujike H, Suzuki M, Inada T, Takeda M, Kaibuchi K, Iwata N, Ozaki N. Analysis of the VAV3 as candidate gene for schizophrenia: evidences from voxel-based morphometry and mutation screening. Schizophr Bull 2013, 39:720-728. 10.1093/schbul/sbs038, 22416266.
67. Lehman NL. The ubiquitin proteasome system in neuropathology. Acta Neuropathol 2009, 118:329-347. 10.1007/s00401-009-0560-x, 19597829.
68. Bayes A, van de Lagemaat LN, Collins MO, Croning MD, Whittle IR, Choudhary JS, Grant SG. Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat Neurosci 2011, 14:19-21. 10.1038/nn.2719, 21170055.
69. Liao P, Soong TW. CaV1.2 channelopathies: from arrhythmias to autism, bipolar disorder, and immunodeficiency. Pflugers Arch 2010, 460:353-359. 10.1007/s00424-009-0753-0, 19916019.
70. Artigas-Pallares J, Gabau-Vila E, Guitart-Feliubadalo M. Syndromic autism: II. Genetic syndromes associated with autism. Rev Neurol 2005, 40:S151-S162. 15736079.
71. Holroyd S, Reiss AL, Bryan RN. Autistic features in Joubert syndrome: a genetic disorder with agenesis of the cerebellar vermis. Biol Psychiatry 1991, 29:287-294. 10.1016/0006-3223(91)91291-X, 2015333.
72. Kumandas S, Akcakus M, Coskun A, Gumus H. Joubert syndrome: review and report of seven new cases. Eur J Neurol 2004, 11:505-510. 10.1111/j.1468-1331.2004.00819.x, 15272893.
73. Ozonoff S, Williams BJ, Gale S, Miller JN. Autism and autistic behavior in Joubert syndrome. J Child Neurol 1999, 14:636-641. 10.1177/088307389901401003, 10511335.
74. Geschwind DH. Autism: many genes, common pathways?. Cell 2008, 135:391-395. 10.1016/j.cell.2008.10.016, 18984147.
75. Greer PL, Greenberg ME. From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 2008, 59:846-860. 10.1016/j.neuron.2008.09.002, 18817726.
76. de la Torre-Ubieta L, Bonni A. Transcriptional regulation of neuronal polarity and morphogenesis in the mammalian brain. Neuron 2011, 72:22-40. 10.1016/j.neuron.2011.09.018, 21982366.
77. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005, 5:472-484. 10.1038/nri1632, 15928679.
78. Muller MR, Rao A. NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol 2010, 10:645-656. 10.1038/nri2818, 20725108.
79. Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002, 35:605-623. 10.1016/S0896-6273(02)00828-0, 12194863.
80. Zhu X, Need AC, Petrovski S, Goldstein DB. One gene, many neuropsychiatric disorders: lessons from Mendelian diseases. Nat Neurosci 2014, 17:773-781. 10.1038/nn.3713, 24866043.
81. Flavell SW, Cowan CW, Kim TK, Greer PL, Lin Y, Paradis S, Griffith EC, Hu LS, Chen C, Greenberg ME. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 2006, 311:1008-1012. 10.1126/science.1122511, 16484497.
82. Dugani CB, Paquin A, Kaplan DR, Miller FD. Coffin-Lowry syndrome: A role for RSK2 in mammalian neurogenesis. Dev Biol 2010, 347:348-359. 10.1016/j.ydbio.2010.08.035, 20832397.
83. Frodin M, Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 1999, 151:65-77. 10.1016/S0303-7207(99)00061-1, 10411321.
84. Anjum R, Blenis J. The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 2008, 9:747-758. 10.1038/nrm2509, 18813292.
85. Du KY, Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 1998, 273:32377-32379. 10.1074/jbc.273.49.32377, 9829964.
86. Kay JC, Xia CM, Liu M, Shen S, Yu SJ, Chung C, Qiao LY. Endogenous PI3K/Akt and NMDAR act independently in the regulation of CREB activity in lumbosacral spinal cord in cystitis. Exp Neurol 2013, 250:366-375. 10.1016/j.expneurol.2013.10.015, 24184018.
87. Rossin EJ, Lage K, Raychaudhuri S, Xavier RJ, Tatar D, Benita Y, Cotsapas C, Daly MJ. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet 2011, 7:e1001273. 10.1371/journal.pgen.1001273, 21249183.